UAE has consistently achieved the topmost position in the list of countries with a high prevalence rate of diabetes. As a result, the diabetes market in the UAE holds special significance due to the profit earned by biopharma companies operating worldwide. Caused by numerous factors, such as hormonal imbalance, unhealthy lifestyle, and irregular eating habits, the diabetic situation in the country has attracted concerns from the healthcare providers and regulatory authorities alike.
To counteract the disease, a lot of focus is being put on the methods of delivering insulin into the bloodstream. One of the technologically advanced, convenient, and popular methods in today’s times is the insulin pen. Some of the major advantages of using an insulin pen include replaceable insulin cartridges, elimination of dosing mistakes, travel handy, and durability. According to our latest research report, “ Diabetes Market in UAE”, the market for insulin pens in UAE is estimated to grow at a CAGR of around 20% during 2011-2013, which will have an overall positive impact on the diabetes market in the country.
Through in-depth and prudent analysis of various industry factors in the UAE, we have identified the prominent developments and drivers that will take the diabetes market in the country to new heights. To provide a clear idea of the scenario in the country, we have provided a patient-profile analysis covering issues of prevalence of diabetes and related problems. For a comprehensive overview of the diabetes market, we have studied the major segments of the market by type, delivery devices, and glucose monitoring.
“ Diabetes Market in UAE” provides a complete overview of the diabetes care market in the country and helps in understanding the future prospects of the same. It also contains critical information about key players along with their business strategies and area of expertise. This will provide clients an additional edge over their competitors, while devising business plans.
For more information visit: http://www.rncos.com/Report/IM247.htm |
